Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New colonoscopy prep could cut hypoglycemia risk in diabetes patients

NCT ID NCT07526103

Symptom relief Sponsor: Queen's University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find a better colonoscopy preparation method for people with diabetes. Current prep methods can cause low blood sugar and poor bowel cleaning. The new approach uses a low-fiber diet the day before and same-day preparation to reduce risks. About 40 adults with diabetes will test this protocol to see if it leads to fewer hypoglycemic events and better colon visualization.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients Age over the age of 18 2. Able to read and understand the English language 3. Confirmed diagnosis of diabetes (Type 1 or Type 2) Exclusion Criteria: 1. Patients without diabetes 2. Patients with prior hospital admission due to hypoglycemic events 3. Patients who have inflammatory bowel disease 4. Patients with ileus or bowel obstruction 5. Patients with history of colorectal resection 6. Patients receiving combined upper and lower endoscopies 7. Patients with ascites 8. Patients with previously documented severe renal impairment 9. Unable to provide consent 10. Pregnant or lactating female (females of child-bearing potential will undergo urine pregnancy testing) 11. Patients who have had a recent myocardial infarction(\<6months) 12. Allergy to product ingredients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colonoscopy (ambulatory patients) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypoglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colonoscopy (ambulatory patients) Diabete mellitus Hypoglycaemia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kingston Health Sciences Centre

    Kingston, Ontario, K7L 2V7, Canada

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.